Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.75M Sell
52,558
-279
-0.5% -$32.7K 0.82% 27
2026
Q1
$6.36M Buy
52,837
+328
+0.6% +$37.9K 0.89% 29
2025
Q4
$5.53M Buy
52,509
+993
+2% +$93.2K 0.8% 29
2025
Q3
$4.32M Buy
51,516
+5,048
+11% +$416K 0.65% 38
2025
Q2
$3.68M Buy
46,468
+3,661
+9% +$291K 0.6% 39
2025
Q1
$3.84M Buy
42,807
+3,685
+9% +$344K 0.68% 38
2024
Q4
$3.89M Buy
39,122
+1,286
+3% +$133K 0.69% 38
2024
Q3
$4.3M Buy
37,836
+950
+3% +$113K 0.78% 34
2024
Q2
$4.57M Sell
36,886
-132
-0.4% -$17K 0.88% 28
2024
Q1
$4.88M Sell
37,018
-812
-2% -$100K 0.98% 25
2023
Q4
$4.12M Buy
37,830
+1,200
+3% +$125K 0.9% 29
2023
Q3
$3.77M Sell
36,630
-344
-0.9% -$37.1K 0.92% 21
2023
Q2
$4.27M Sell
36,974
-296
-0.8% -$33.6K 1.03% 20
2023
Q1
$3.97M Buy
37,270
+905
+2% +$97.7K 1.01% 22
2022
Q4
$4.03M Buy
36,365
+1,885
+5% +$193K 1.11% 21
2022
Q3
$2.97M Sell
34,480
-6,018
-15% -$537K 1.03% 21
2022
Q2
$3.69M Buy
40,498
+341
+0.8% +$30.2K 0.96% 28
2022
Q1
$3.29M Buy
40,157
+3,627
+10% +$286K 0.86% 30
2021
Q4
$2.8M Buy
36,530
+638
+2% +$50.8K 0.75% 35
2021
Q3
$2.7M Buy
35,892
+3,177
+10% +$242K 0.78% 37
2021
Q2
$2.54M Buy
32,715
+3,456
+12% +$257K 0.75% 38
2021
Q1
$2.15M Buy
29,259
+26,588
+995% +$1.96M 0.64% 43
2020
Q4
$209K Buy
2,671
+71
+3% +$5.43K 0.07% 117
2020
Q3
$206K Buy
2,600
+129
+5% +$10.1K 0.07% 116
2020
Q2
$182K Sell
2,471
-124
-5% -$9.34K 0.08% 116
2020
Q1
$190K Buy
2,595
+98
+4% +$7.7K 0.1% 106
2019
Q4
$215 Buy
+2,497
New +$205K 0.1% 108

Other funds holding MRK

Leelyn Smith's MRK Position: Q2 2026 in Review

Leelyn Smith reduced its Merck (MRK) stake by 0.53% in Q2 2026, selling an estimated $32.7K and leaving 52,558 shares worth $6.75M. The position accounts for 0.82% of the portfolio, ranked #27.

Leelyn Smith first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 1,778 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Leelyn Smith held 52,558 shares of Merck worth $6.75M as of Q2 2026.
  • Leelyn Smith sold 279 Merck shares in Q2 2026, an estimated $32.7K.
  • Merck made up 0.82% of Leelyn Smith's portfolio in Q2 2026, its #27 holding.
  • Leelyn Smith first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • 1,778 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.